Amgen Inc. (AMGN – Analyst Report) just released their fourth quarter fiscal 2015 earnings results, posting earnings of $2.61 and revenue of $5.54 billion.

Currently, AMGN has a Zacks Rank #3 (Hold), but it is subject to change following the release of the company’s latest earnings report. Here are 5 key statistics from this just announced report below.

Amgen:                                                 

Beat earnings estimates. The company posted $2.61, beating our Zacks Consensus Estimate of $2.27. This number excludes $0.24 from non-recurring items.

Beat revenue estimates. The company saw revenue figures of $5.54 billion, just surpassing our estimate of $5.532 billion, an increase of 4%.

Posted operating income of $2.03 billion and net income of $1.8 billion.

“2015 was an exceptional year for Amgen with six innovative new launches, strong financial performance, continued pipeline advances and improved operating margins driven by our transformation efforts,” said Robert A. Bradway, chairman and chief executive officer. “We remain on track to meet or exceed our 2018 commitments and deliver value for patients and shareholders.”

AMGN was up $0.65, or 0.44%, to $149.00 as of 4:40 PM ET in after hours trading shortly after its earnings report was released.

Here’s a graph that looks at Amgen’s long-term quarterly net income and profit margin:

Amgen Inc. (AMGN – Analyst Report) Quarterly Net Income & Profit Margin | FindTheCompany

Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science’s promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people’s lives. Amgen was founded in 1980 and is headquartered in Thousand Oaks, California.